Unaudited Condensed Interim Consolidated Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Income Statement [Abstract]
Net Sales	$ 5,907,646	$ 1,884,320	$ 9,263,736	$ 4,196,935
Cost of Goods Sold	4,603,854	1,351,091	6,810,845	2,739,440
Gross Profit	1,303,792	533,229	2,452,891	1,457,495
Operating Expenses
Research and development	82,049	9,763	141,363	53,408
Selling. general and administrative expenses	4,031,215	2,698,482	7,132,441	4,299,999
Loss on impairment of goodwill			1,138,203
Total Operating Expenses	4,113,264	2,708,245	8,412,007	4,353,407
Operating Loss	(2,809,472)	(2,175,016)	(5,959,116)	(2,895,912)
Other Income (Expense)
Change in Fair Market Value of Warrant Liability	(32,111)	10,948	11,717	(300,452)
Interest expense	(49,020)		(53,076)
Loss on change in Fair Market Value of Contingent Consideration			(240,000)
Gain on Settlement of Contingent Consideration (Note 2)			1,700,000
Other Income	1,948	25,837	1,948	25,182
Total Other Income (Expense)	(79,183)	36,785	1,420,589	(275,270)
Loss Before Provision for Income Taxes	(2,888,655)	(2,138,231)	(4,538,527)	(3,171,182)
Provision from Income Taxes
Net Loss	(2,888,655)	(2,138,231)	(4,538,527)	(3,171,182)
Net Loss attributable to common stockholders:
Dividends to preferred shareholders	(362,250)		(724,500)
Net Loss attributable to common stockholders	$ (3,250,905)	$ (2,138,231)	$ (5,263,027)	$ (3,171,182)
Basic and Diluted Loss Per Common Share	$ (0.26)	$ (0.23)	$ (0.41)	$ (0.35)
Weighted Average Shares Outstanding - basic and diluted	12,665,385	9,407,367	12,799,783	9,102,677